R. Hutchings
R. Hutchings publishes mostly in Rheumatology, Pathology and Forensic Medicine and Genetics, on topics such as Rheumatoid Arthritis Research and Therapies, Chronic Lymphocytic Leukemia Research and Spondyloarthritis Studies and Treatments.
- World rank
- #5,875,849 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #332,207 of 367,258
- Works
- 60
- Citations
- 142
- Citations per work
- 2.4
What does R. Hutchings research?
R. Hutchings's work is mostly in Medicine (52%), Immunology and Microbiology (6%), Economics, Econometrics and Finance (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3152.0%
- Medicine3152.0%
- Everything else2337.7%
- Life Sciences46.2%
- Social Sciences24.1%
- 1Rheumatology33% of their works
- 2Pathology and Forensic Medicine8% of their works
- 3Genetics7% of their works
- 4Immunology6% of their works
- 5Radiology, Nuclear Medicine and Imaging5% of their works
- 6Economics and Econometrics4% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Chronic Lymphocytic Leukemia Research
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Lymphoma Diagnosis and Treatment
- Monoclonal and Polyclonal Antibodies Research
- Psoriasis: Treatment and Pathogenesis
- Biosimilars and Bioanalytical Methods
Which keywords describe R. Hutchings's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Rituximab, Monoclonal Antibodies, Ankylosing Spondylitis, Chronic Lymphocytic Leukemia and Genomic Aberrations.
- Immunogenicity
- Biosimilars
- Lymphoma
- Classification
- Antiphospholipid Syndrome
- Genomic Aberrations
- Ankylosing Spondylitis
- Rituximab
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- Monoclonal Antibodies
- Chronic Lymphocytic Leukemia
- Spondyloarthritis
- Systemic Lupus Erythematosus
- Fc Receptors
- Therapeutic Antibodies
- IL-17
- TH17 Cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Autoantibodies382 topics
- Inflammation291 topic
- Rheumatoid Arthritis291 topic
- Rituximab172 topics
- Monoclonal Antibodies112 topics
- Ankylosing Spondylitis101 topic
- Chronic Lymphocytic Leukemia101 topic
- Genomic Aberrations101 topic
- Spondyloarthritis101 topic
- Antiphospholipid Syndrome91 topic
- Systemic Lupus Erythematosus91 topic
- Classification71 topic
- Fc Receptors71 topic
- Lymphoma71 topic
- Therapeutic Antibodies71 topic
- Biosimilars41 topic
- IL-1741 topic
- Immunogenicity41 topic
- TH17 Cells41 topic
Where does R. Hutchings work?
R. Hutchings's main affiliation in the publication record is Ipsos (United Kingdom), United Kingdom.
How many publications and citations does R. Hutchings have?
OpenAlex counts 60 works and 142 citations for R. Hutchings, an h-index of 5, ranking #5,875,849 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named R. Hutchings
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about R. Hutchings. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.